GB201408527D0 - Drug reducing possible hormonal effects of scarring - Google Patents
Drug reducing possible hormonal effects of scarringInfo
- Publication number
- GB201408527D0 GB201408527D0 GB201408527A GB201408527A GB201408527D0 GB 201408527 D0 GB201408527 D0 GB 201408527D0 GB 201408527 A GB201408527 A GB 201408527A GB 201408527 A GB201408527 A GB 201408527A GB 201408527 D0 GB201408527 D0 GB 201408527D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- scarring
- reducing possible
- hormonal effects
- drug reducing
- possible hormonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201408527A GB201408527D0 (en) | 2014-05-14 | 2014-05-14 | Drug reducing possible hormonal effects of scarring |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201408527A GB201408527D0 (en) | 2014-05-14 | 2014-05-14 | Drug reducing possible hormonal effects of scarring |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201408527D0 true GB201408527D0 (en) | 2014-06-25 |
Family
ID=51032734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201408527A Ceased GB201408527D0 (en) | 2014-05-14 | 2014-05-14 | Drug reducing possible hormonal effects of scarring |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201408527D0 (en) |
-
2014
- 2014-05-14 GB GB201408527A patent/GB201408527D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280785A (en) | Human plasma kallikrein inhibitors | |
IL251584A0 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
IL250685A0 (en) | Cytotoxicity-inducing therapeutic agent | |
IL246902B (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
HK1258062A1 (en) | Methods of administering elagolix | |
PT3096740T (en) | Pharmaceutical composition comprising brinzolamide | |
IL285882A (en) | Therapeutic uses of l-4-chlorokynurenine | |
HK1244711A1 (en) | Treatment of hmgb1-mediated inflammation | |
EP3193847A4 (en) | Injectable microparticles for hyper-localized release of therapeutic agents | |
GB201419540D0 (en) | Delivery of drugs | |
IL251350A0 (en) | Treatment of rett syndrome | |
HK1204916A1 (en) | Pharmaceutical application of anhydroicaritin | |
IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
GB201408527D0 (en) | Drug reducing possible hormonal effects of scarring | |
GB201513922D0 (en) | Treatment of hyperpigmentation | |
IL236381A0 (en) | Pharmaceutical compositions for treatment of cancer | |
GB201413797D0 (en) | Healing concept | |
GB201409272D0 (en) | Synergistic combination of analgesic drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |